Marta
Rodríguez González
Profesora Asociada CC. Salud
German Cancer Research Center
Heidelberg, AlemaniaPublicaciones en colaboración con investigadores/as de German Cancer Research Center (1)
2019
-
Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia
International Journal of Cancer, Vol. 144, Núm. 11, pp. 2762-2773